NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,222.49 +21.22 (+0.12%) CRUDE OIL
82.89 +0.08 (+0.10%) GOLD FUTURES
2,331.90 -6.50 (-0.28%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,393.61 -2,036.79 (-3.81%)
Heron Therapeutics, Inc. (0J4V.L)
- PR Newswire
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, May 7, 2024, at 8:30 a.m. ET to report first quarter 2024 financial results and discuss recent business highlights.
- PR Newswire
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it will host an Investor Day on Wednesday, May 15, 2024 in New York City, beginning at 9:30 am ET. The event will include presentations from members of the Company's leadership team highlighting the renewed focus across the Acute Care and Oncology franchises and panel discussions featuring patient and physician experience with Heron's commercial products. The presentations will also include up
- PR Newswire
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate in a fireside chat on Wednesday, April 10, 2024, at 11:00 AM ET at the 23rd Annual Needham Virtual Healthcare Conference. The conference is being held in a virtual format, April 8-11, 2024.
